2015
DOI: 10.1016/j.jcjo.2014.11.005
|View full text |Cite
|
Sign up to set email alerts
|

SUNDROP: six years of screening for retinopathy of prematurity with telemedicine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
95
0
5

Year Published

2015
2015
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 141 publications
(101 citation statements)
references
References 35 publications
1
95
0
5
Order By: Relevance
“…A retrospective analysis at the Stanford University program demonstrated sensitivity and specificity approaching 100%, without any adverse events in more than 1000 eyes. 12 …”
Section: Hospital-based Evaluationsmentioning
confidence: 99%
“…A retrospective analysis at the Stanford University program demonstrated sensitivity and specificity approaching 100%, without any adverse events in more than 1000 eyes. 12 …”
Section: Hospital-based Evaluationsmentioning
confidence: 99%
“…Recent studies have shown that telemedicine for ROP screening can be safe and effective. 49 Our “Telemedicine approaches to evaluating acute-phase retinopathy of prematurity” (e-ROP) Study demonstrated that a telemedicine system using non-physician imagers and non-physician trained readers for detection of referral-warranted ROP (RW-ROP, defined as Zone I disease, Stage 3 disease or worse, or plus disease) is valid, safe and cost-effective. 5;1012 …”
Section: Introductionmentioning
confidence: 99%
“…The efficacy of teleretinal screening for ROP using RetCam has been validated in several studies. [27][28][29][35][36][37][38][39][40][41]44 Notably, the Recently, the multicenter Telemedicine Approaches to Evaluating AcutePhase Retinopathy of Prematurity (e-ROP) study created a grading system for digital ROP images, where nonphysicians were successfully trained to grade and screen for patients with referral-warranted ROP. 45 These findings suggest that telemedicine appears to be a safe, reliable, and cost-effective complement to direct examinations by ROP specialists, with the potential to increase screening and extend treatment to infants with vision-threatening disease.…”
Section: Pediatric Retinal Diseasesmentioning
confidence: 99%